Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Unzeta

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Neurochemistry International|November 13, 2002
PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 miceVirgili Perez, Mercedes Unzeta
Biology of the Cell|August 9, 2011
Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseasesMontse Solé, Mercedes Unzeta
International Review of Neurobiology|October 6, 2011
Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's diseaseMercedes Unzeta, Elisenda Sanz
Cerebrovascular Diseases (Basel, Switzerland)|February 8, 2014
Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemiaPing Sun, Montse Solé, Mercedes Unzeta
Journal of Neural Transmission (Vienna, Austria : 1996)|December 15, 2012
Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitorsIrene Bolea, Alejandro Gella, Mercedes Unzeta
Developmental Dynamics : an Official Publication of the American Association of Anatomists|August 30, 2008
SSAO/VAP-1 protein expression during mouse embryonic developmentTony Valente, Montse Solé, Mercedes Unzeta
Neuroscience Letters|August 8, 2002
Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesionBlanca Cutillas, Santiago Ambrosio, Mercedes Unzeta
Biochimica Et Biophysica Acta|February 2, 2006
Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cellsMar Hernandez, Montse Solé, Mercè Boada, et al.
Neurobiology of Aging|December 3, 2014
Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-ADMontse Solé, Alfredo J Miñano-Molina, Mercedes Unzeta
Neuroscience Letters|March 2, 2002
Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathyI Ferrer, J M Lizcano, M Hernández, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Neurochemistry International|November 13, 2002
PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 miceVirgili Perez, Mercedes Unzeta
Biology of the Cell|August 9, 2011
Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseasesMontse Solé, Mercedes Unzeta
International Review of Neurobiology|October 6, 2011
Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's diseaseMercedes Unzeta, Elisenda Sanz
Cerebrovascular Diseases (Basel, Switzerland)|February 8, 2014
Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemiaPing Sun, Montse Solé, Mercedes Unzeta
Journal of Neural Transmission (Vienna, Austria : 1996)|December 15, 2012
Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitorsIrene Bolea, Alejandro Gella, Mercedes Unzeta
Developmental Dynamics : an Official Publication of the American Association of Anatomists|August 30, 2008
SSAO/VAP-1 protein expression during mouse embryonic developmentTony Valente, Montse Solé, Mercedes Unzeta
Neuroscience Letters|August 8, 2002
Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesionBlanca Cutillas, Santiago Ambrosio, Mercedes Unzeta
Biochimica Et Biophysica Acta|February 2, 2006
Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cellsMar Hernandez, Montse Solé, Mercè Boada, et al.
Neurobiology of Aging|December 3, 2014
Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-ADMontse Solé, Alfredo J Miñano-Molina, Mercedes Unzeta
Neuroscience Letters|March 2, 2002
Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathyI Ferrer, J M Lizcano, M Hernández, et al.
Pageof 7